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Abstract
Wastewater-based epidemiology is an innovative approach that uses the analysis
of human excretion products in wastewater to obtain information about exposure to drugs
in defined population groups. We developed and validated an analytical method for the
detection and

quantification

of opioids

(morphine,

oxycodone,

hydrocodone,

oxymorphone and hydromorphone), and cannabinoids (9-tetrahydrocannabinol, 11-nor9-carboxy- tetrahydrocannabinol (THCCOOH) and THCCOOH-glucuronide) in rawinfluent wastewater samples by ultra-high performance liquid chromatography-tandem
mass spectrometry. Method validation included linearity (5–1 000 ng/L for opioids, 10–1
000 ng/L for cannabinoids), imprecision (<21.2%), accuracy (83%–131%), matrix effect
(from –35.1% to –14.7%) and extraction efficiency (25%–84%), limit of detection (1–5
ng/L) and quantification (5–10 ng/L) and auto-sampler stability (no loss detected). River,
sewage overflow and wastewater samples were collected in triplicate from different
locations in New York City and stored at -20 C until analysis. River water samples were
negative for all the compounds. Water from sewage overflow location tested positive for
morphine (10.7 ng/L), oxycodone (4.2–23.5 ng/L), oxymorphone (4.8 ng/L) and
hydromorphone (4.2 ng/L). Wastewater samples tested positive for morphine (133.0–
258.3 ng/L), oxycodone (31.1– 63.6 ng/L), oxymorphone (16.0–56.8 ng/L),
hydromorphone (6.8–18.0 ng/L), hydrocodone (4.0– 12.8 ng/L) and THCCOOH (168.2–
772.0 ng/L). This method is sensitive and specific for opioids and marijuana
determination in wastewater samples.
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Introduction
Wastewater analysis is becoming the method of choice for determining what drug(s) are
being used within geographical areas that wastewater treatment plants service
(Castiglioni, Thomas, Kasprzyk-Hordern, Vandam, & Griffiths, 2014). By observing
human biomarkers in sewage water, analysts can monitor the consumption of various
drugs. These findings can then be compared to, and even supplement, traditional
anonymous surveys. Wastewater epidemiology/toxicology is inexpensive, provides
virtually real-time data, and is reliable for assessing the extent of drug use in a
geographical region of interest. Its ability to rapidly determine drug use trends in an area
can help with the development of targeted public health programs and policy initiatives in
these specific communities. However, some disadvantages of wastewater analysis include
uncertainties because of population flow variations (e.g. with tourists, peak travel
holidays), sewage flow changes, rainfall, and varying inter-individual drug excretion
rates (Daghir & Markuszewski, 2010; Daughton, 2011). Whereas wastewater analysis is a
rapidly growing field in Europe (EMCDDA, 2016), data for the evaluation of wastewater
in the United States (USA) are scarce (Daughton, 2011; Subedi & Kannan, 2015). This
type of study has never been performed in New York City (NYC), which is the largest
city in the USA.
Prescription opioids are used to treat chronic pain, and their use has increased
dramatically in recent years. This has been strongly associated with increasing rates of
nonmedical use of prescription opioids in the USA (Paulozzi, Mack, & Hockenberry,
2014). This situation has led to opioids being the most abused class of prescription drugs
(Nationwide Trends, 2015). According to statistics from the New York City Health
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Department, 59 opioid-related deaths occurred in 2000, and this increased to 220 opioidrelated deaths in 2013 (http://www1. nyc.gov/site/doh/health/health-topics/alcohol-anddrug-use-data-tables.page). Between 2005 and 2014, the rate of deaths because of
prescription opioids increased 250% (rate of increase per 100 000 general population). In
2005, prescription opioids contributed to 29% of the drug overdoses in New York, and
this

figure

rose

to

43%

by

state.ny.us/press/releases/june16/heroin_and_opioids.pdf).

2014
According

(http://www.osc.
to

the

2014

National Survey on Drug Use and Health (Center for Behavioral Health Statistics and
Quality, 2015), 4.3 million people aged 12 or older have reported current nonmedical use
of prescription pain relievers.
In the USA, marijuana is the most commonly used illicit drug, with 22.2 million
marijuana users aged 12 or older that have used the drug in the past month (past-month
users) (Center for Behavioral Health Statistics and Quality, (2015). This is followed by
stimulants (1.6 million past-month users), cocaine (1.5 million past-month users) and
heroin (400,000 past-month users). Based on National Statistics, 44% of adolescents 12
years and older have used marijuana in their lifetime, which is about the same percentage
as individuals aged 26 and older. Individuals aged 18 to 25 years old have the highest
percentage of marijuana users (52%) (https://www.drugabuse.gov/national-survey-druguse-health). On July 7 2014, New York became the 23rd state to legalize medical
marijuana

(https://www.

health.ny.gov/regulations/medical_marijuana/),

allowing

medical facilities in eight cities to prescribe capsules, liquids, oils, or vaporizable forms
of cannabis. The effect of marijuana legalization on prevalence of use is still unknown.
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Several authors have published methods for the determination of licit and illicit
drugs in wastewater (Baker & Kasprzyk-Hordern, 2011; Berset, Brenneisen, & Mathieu,
2010; Bijlsma, Sancho, Pitarch, Ibáñez, & Hernández, 2009; Bisceglia, Lynn Roberts,
Schantz, & Lippa, 2010; Boleda, Galceran, & Ventura, 2007; Castiglioni et al., 2006;
Chiaia, Banta-Green, & Field, 2008; Fedorova, Randak, Lindberg, & Grabic, 2013;
González-Mariño, Quintana, Rodríguez, Gonzáez-Díez, & Cela, 2012; Gul, Stamper,
Godfrey, Gul, & ElSohly, 2016; Heuett, Ramirez, Fernandez, & Gardinali, 2015;
Hummel, Löffler, Fink, & Ternes, 2006; Mastroianni, Postigo, De Alda, & Barcelo,
2013; Postigo & Alda, 2008; Senta, Krizman, Ahel, & Terzic, 2013; Vazquez-Roig,
Andreu, Blasco, & Picó, 2010). However, prescription opioid data are scarce, and
wastewater samples have never been analyzed for the major cannabis metabolite in
human

urine,

11-nor-9-carboxy-tetrahydrocannabinol-glucuronide

(THCCOOH-

glucuronide). The objective of this study was to develop and validate an analytical
method for the detection of morphine, common prescription opioids (oxycodone,
oxymorphone,

hydrocodone

and

hydromorphone)

and

cannabinoids

(9-

tetrahydrocannabinol (THC) and its metabolites THCCOOH and THCCOOHglucuronide) in wastewater samples. Then, for proof of concept, this method was applied
to river water, sewage overflow and wastewater samples collected from different
locations within NYC.
Materials and methods
Reagents and materials
Morphine,

oxycodone,

hydrocodone,

oxymorphone,

hydromorphone,

9-

tetrahydrocannabinol (THC) and its metabolites 11-nor-9-carboxy-tetrahydrocannabinol
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(THCCOOH) and THCCOOH-glucuronide were purchased from Cerilliant (Round Rock,
TX, USA). The deuterated analogs THC-d3, THCCOOH-d3, THCCOOH-glucuronide-d3,
morphine-d3, oxycodone-d6, hydrocodone-d6, oxymorphone-d3 and hydromorphone-d6
were also purchased from Cerilliant. Strata XC 33 mm polymeric strong cation exchange
cartridges of 3 mL/60 mg for calibrators and 6 mL/200 mg for quality control (QC) and
authentic wastewater samples were purchased from Phenomenex (Torrance, CA, USA).
Hydrochloric acid (HCl), ultra-high performance liquid chromatography (UHPLC) grade
methanol,

dichloromethane

and

ammonium

hydroxide

was

purchased

from

PharmcoAaper (Brookfield, CT, USA). Isopropanol, liquid chromatography mass
spectrometry grade acetonitrile, and Whatman glass microfiber filters (outside diameter
4.7 cm, particle retention 1.6 mm, and thickness 0.26 mm) were from Thermo Fisher
Scientific (Waltham, MA, USA).
Method Optimization
To ensure the best method would be implemented for the extraction and analysis of target
compounds in wastewater samples, mass spectrometry (MS) optimization of each
compound (precursor and product ions) was performed. After which, multiple extraction
methods, solid phase extraction cartridges, liquid chromatography columns and
separation programs/ reconstitution solutions were tested.
MS optimization of compounds involved injecting 1 or 2 L of individual
solutions of each compound at either 0.1 or 1 g/mL. The precursor ion and all products
produced from that precursor ion at various collision energies were manually reviewed.
Product ions created in the most abundance and with consistency across energies were
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chosen as quantifier or qualifier, and the respective voltages of the two quadrupoles and
the collision energy cell was recorded.
To obtain the best separation among compounds in a short period of time,
different columns and gradients were attempted. Two types of columns were tested (C-18
and EVO) to ascertain which would provide the best Gaussian peak shapes and great
separation. The mobile phase was a mixture of A (0.1% formic acid in water) and B
(0.1% formic acid in acetonitrile).
A variety of solid phase extraction (SPE) cartridges were tested with different
extraction procedures to ascertain which would give the best yield for all compounds of
interest. SPE cartridges included Oasis HLB, Hypersep Verify Ax, Strata X-B Drug, and
Strata XC cartridges. Extraction steps (conditioning, loading, washing, drying, and
eluting) were optimized by using solvent mixtures on the same cartridge type to compare
yields. Test samples were prepared in either diluted hydrochloric acid or diluted acetic
acid for the load step. Depending on the cartridge type, washing steps varied from acidic
to basic with the use of ammonium hydroxide, acetic acid or hydrochloric acid, along
with methanol and water. The elution step varied as well depending on the cartridge type
by utilizing a combination of solvents such as ethyl acetate/ isopropanol/ ammonium
hydroxide, dichloromethane/ isopropanol, dichloromethane/ isopropanol/ ammonium
hydroxide or methanol/ ammonium hydroxide in different percentages. Elution was also
tested as a 1-step or 2-step process.
Instrumentation
The chromatographic separations were carried out on an UHPLC–tandem mass
spectrometry (MS/MS) instrument from Shimadzu (Kyoto, Japan). The Nexera UHPLC
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system consisted of a binary LC-20ADXR high-performance liquid chromatography
pump, Nexera LC-30AD micro mixer, online degassing unit (DGU-20A3R) and cooled
autosampler (SIL-20SCHT UFLC). The chromatographic column was a Kinetex C18 (2.1
mm x 100 mm, 1.7 mm particle size, 100 A pore size) and the guard column was a
SecurityGuard ULTRA Cartridges C18 (2.1 mm, Phenomenex). Mobile phase A was
0.1% formic acid in water and mobile phase B was 0.1% formic acid in acetonitrile. The
following gradient program was used for elution of cannabinoids: held at 40% B for 4
min, increased to 95% B and held for 1 min, decreased to 40% B in 0.5 min and held at
40% B for 1.5 min (Figure 1.). The total run time was 7 min and the mobile phase flow
rate was 0.5 mL/min. The following gradient program was used for elution of opioids:
held at 2% B for 1 min, increased to 30% B in 3 min, increased to 95% B in 2 min and
held for 1 min, decreased to 2% B in 0.5 min and held for 2.5 min (Figure 2.). The total
run time was 10 min and the mobile phase flow rate was 0.3 mL/min. The column oven
was operated at 40 C for both gradients. The injection volume was 50 µL for each set of
compounds.
The mass spectrometer was a triple quadrupole LC- MS 8030 from Shimadzu
equipped with a dual ionization source (atmospheric pressure chemical ionization and
electrospray ionization). The nebulizing gas flow was set to 2 L/min, the desolvation line
was at 250 C, the heating block was at 400 C and the drying gas flow was at 15 L/min.
The dual ionization source corona needle voltage and interface voltage were both set to
4.5 kV. Two multiple reaction monitoring (MRM) transitions were monitored for each
compound (Table 1), with one used as a quantifier and the other as a qualifier.
Sample preparation
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An aliquot (100 mL) of each wastewater sample was measured using a graduated
cylinder and placed in a beaker, spiked with 50 µL of internal standard mixture (0.1
g/mL), and filtered through a glass microfiber filter. Then, 0.5 mL of HCl was added
immediately to acidify the solution to maximize retention onto mixed- mode cartridges.
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Figure 1. Liquid chromatography gradient for cannabinoids. Mobile phase A was 0.1% formic acid in
water and B 0.1% formic acid in acetonitrile.
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Figure 2. Liquid chromatography gradient for opioids. Mobile phase A was 0.1% formic acid in water
and B 0.1% formic acid in acetonitrile.

Solid phase extraction
Strata XC 6 mL/200 mg cartridges were conditioned with 6 mL of methanol, 6 mL of
ultra-high purity (UHP) water, and 6 mL of 0.1% HCl. Then the 100 mL of acidified
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wastewater was manually loaded 6 mL at a time (17 times) onto a cartridge with a small
vacuum (<34 473 Pa). The cartridges were washed with 4 mL of UHP water and 4 mL of
0.1% HCl, and then dried under vacuum for 15 min. Finally, 8 mL of elution solvent
(Vdichloromethane:Visopropanol: Vammonium

hydroxide

 78:20:2) was added. A vacuum was applied

to retrieve all the solvent, and the eluate was split in half. The opioid samples were
labelled set 1, and the cannabinoid samples were labelled set 2. Each set was evaporated
to dryness under a steady stream of N2 in a Biotage TurboVap (Uppsala, Sweden) at 40
C. The opioid samples (set 1) were reconstituted in 200 L of UHP water, and the
cannabinoid samples (set 2) were reconstituted in 200 L of a mixture (VA:VB = 60:40)
of mobile phases A (0.1% formic acid in water) and B (0.1% formic acid in acetonitrile).
Calibrators, quality controls and internal standards
An internal standard working solution was prepared by diluting each ampoule with pure
methanol and combining all analogues to a final concentration of 0.1 g/mL in methanol.
Stock solutions of each compound were prepared in pure methanol (at either 10 or 100
g/mL) and combined to a stock concentration of 1 g/mL. This solution was then
serially diluted to concentrations of 0.001, 0.01, 0.1, and 1 g/mL and used to prepare
quality control and calibration curve samples at concentrations of 0.5, 1, 3, 5, 10, 50, 100,
500 and 1 000 ng/L.
To reduce the cost and time of this process, calibrators were prepared in 3 mL of UHP
water and spiked with the corresponding calibration working solution to match
concentrations of 5 to 1 000 ng/L in a 100 mL sample. For the calibration curve, clean
test tubes were prepared by adding 3 mL of UHP water, 50 µL of internal standard
mixture (0.1 g/mL), and the following volumes of the respective calibrator working
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solution: 50 and 100 L of the 0.01 g/mL solution for 5 and 10 ng/L calibrators, 50 and
100 L of the 0.1 g/mL solution for 50 and 100 ng/L calibrators, and 50 and 100 L of
the 1 g/mL solution for 500 and 1 000 ng/L calibrators. Lastly, 15 L of HCl (0.5%)
was added before vortex mixing and SPE. Strata XC 3 mL/60 mg cartridges were
conditioned with 3 mL of methanol, followed by 3 mL of UHP water and 3 mL of 0.1%
HCl. The acidified calibrator was loaded onto the mixed-mode cartridge. Cartridges were
washed with 2 mL of UHP water and 2 mL of 0.1% HCl, and then dried under vacuum
for 15 min. Sample elution was performed with 4 mL of a
dichloromethane/isopropanol/ammonium hydroxide mixture (V dichloromethane:Visopropanol:
Vammonium hydroxide  78:20:2).

Table 1. MRM transitions, retention time (RT), and precursor ion for each analyte of interest.

Compound

RT (min)

Precursor ion
(m/z)

Quantifier
product ion
(m/z)

Collision
energy1 (eV)

Qualifier
product ion
(m/z)

Collision
energy2 (eV)

Morphine

3.14

286

165

-40

181

-33

Morphine-d3

3.13

289

164

-44

153

-43

Hydromorphone

3.44

286

184

-33

157

-43

Hydromorphone-d6

3.42

292

185

-33

157

-49

Oxymorphone

3.29

302

226

-32

242

-28

Oxymorphone-d3

3.29

304

201

-45

230

-31

Oxycodone

3.98

316

256

-26

212

-46

Oxycodone-d6

3.97

322

247

-31

262

-29

Hydrocodone

4.10

300

199

-31

170

-40

Hydrocodone-d6

4.08

306

202

-36

174

-44

THC

4.01

315

193

-23

122

-38

THC-d3

4.00

318

195

-27

122

-39

THCCOOH

2.87

345

299

-21

192

-28

THCCOOH-d3

2.86

348

330

-17

302

-23

10
THCCOOHGlucuronide

1.98

521

345

-15

326

-18

THCCOOHGlucunoride-d3

1.94

524

348

-15

330

-21

1Collision
2Collision

energy for Quantifier production
energy for Qualifier production

The eluate was split in half. The samples were labelled as set 1 for opioids and set 2 for
cannabinoids. Each set was evaporated to dryness under a steady stream of N2 in a
Biotage TurboVap at 40 C. Opioid samples (set 1) were reconstituted in 200 L of UHP
water, and cannabinoids samples (set 2) were reconstituted in 200 L of a mixture
(VA:VB  60:40) of mobile phases A (0.1% formic acid in water) and B (0.1% formic
acid in acetonitrile).
QC samples were prepared at 10 and 100 ng/L by spiking 100 mL of UHP water with the
required amount of the working solution and 50 L of the internal standard mixture.
These samples were then filtered, and 0.5 mL of HCl was added before SPE.
Authentic sample collection
For proof of concept, 33 samples were collected from river water (22 samples), sewage
overflow (6 samples) and raw influent from wastewater treatment plants (5 samples) in
NYC. River samples were collected from the Hudson and East Rivers in the Bronx,
Manhattan, Queens and Roosevelt Island. Sewage overflow samples were collected from
Newtown Creek (Brooklyn), and wastewater samples were collected from the Tallman
and Jamaica wastewater treatment plants in Queens. Samples were collected for 1–3 days
before and after national holidays (Independence Day, July 4 2015; Labor Day,
September 7 2015; New Year’s Day, January 1 2016) and on March 25th and 30th 2016.
The samples were collected at one time point on each of these days (between 7 and 11
am) in 200 mL Nalgene Certified Wide-Mouth Amber high-density polyurethane
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bottles (Thermo Fisher Scientific). To prevent degradation of the target drugs, the
samples were stored in a freezer at –20 C until required for analysis.
Validation parameters
The method was validated using various procedures outlined by the Scientific Working
Group for Forensic Toxicology guidelines (“Scientific working group for forensic
toxicology (SWGTOX) standard practices for method validation in forensic toxicology,”
2013) for the linearity, limit of detection (LOD), limit of quantification (LOQ),
interferences (specificity), autosampler stability, imprecision, accuracy, carryover,
extraction efficiency, process efficiency and matrix effect.
Linearity was determined over five different days by least-squares regression and
different weighting factors (none, 1/x and 1/x2) were evaluated. The linearity was
acceptable if the coefficient of determination (R2) was  0.99 and the residuals were
within 20%. The LOD and the LOQ were evaluated with decreasing analyte
concentrations in spiked samples from three different sources. The LOD was the lowest
concentration with acceptable chromatography, a signal-to-noise ratio > 3, the presence
of all product ions, the correct ion ratio (within ±20% of the average of the calibrators)
and a suitable retention time (within ±0.2 min of the retention time of the calibrators).
The LOQ satisfied the LOD criteria and was quantified within ±20% imprecision and
80%–120% accuracy.
Interferences from matrix components were evaluated by analyzing river (n =22)
and wastewater (n = 4) samples negative for the compounds of interest, after spiking with
the internal standard solution. Interferences were considered insignificant if the analytes
of interest were not detected in these samples. Method specificity was demonstrated by
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analyzing high concentrations (1,000 ng/L) of potentially interfering drugs. The
following compounds and their metabolites were examined: opioids (morphine-3glucuronide, morphine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3glucuronide, oxymorphone-6-glucuronide and 6-acetylmorphine), cannabinoids (11hydroxy-THC, cannabinol, and cannabidiol) and common drugs of abuse (cocaine,
benzoylecgonine, amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine,
3,4-methylenedioxymethamphetamine and methadone). Sufficient specificity was
achieved if the analytes of interest were below the LOD.
To determine carryover, blank samples spiked with the internal standard (negative
calibrator) were injected immediately after samples spiked at 2,000 ng/L (twice the
highest calibrator concentration). The carryover was considered negligible if the
measured concentration was less than the LOD. Before SPE, the 2,000 ng/L samples
were prepared using 3 mL of UHP water and spiking it with 50 L of internal standard,
200 L of the 1 g/mL calibrator solution and 15 L of HCl.
Inter- and intra-day QC samples at 10 ng/L and 100 ng/L were prepared with 100
mL of UHP water spiked with 100 L of the 0.01 g/mL solution (for 10 ng/L
concentration) or the 0.1 g/mL solution (for 100 ng/L concentration). The imprecision
and accuracy were determined at these two concentrations with four repeat analyses in
one day (intra-day n = 4) and over five days (inter-day n = 5). The imprecision was
determined using the coefficient of variation of the measured values and expected to be
less than 20%. The intra- and inter-day imprecision were calculated as the standard
deviation of the QC concentrations x 100/ mean QC concentrations. The accuracy was
calculated as a percentage of the target concentration, and was required to be within
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80%–120%. The intra- and inter- day accuracy was calculated as the mean QC
concentrations x 100/QC target concentration.
Autosampler stability was evaluated by reinjecting four QC samples after 24 h in
the autosampler at 10 °C. The QC samples were prepared at 10 ng/L using 100 mL of
UHP water and 100 L of 0.01 g/mL calibrator working solution. The concentrations
within ±20% of the initial concentration were considered acceptable.
To evaluate the matrix effect, extraction efficiency and process efficiency, three sets of
samples were prepared in duplicate at the same concentration (10 ng/L). Set 1 contained
neat samples prepared by adding 2 mL of elution solvent, 50 L of internal standard, and
100 L of the 0.01 g/mL solution to a clean test tube. This sample was then split,
evaporated to dryness and reconstituted in the appropriate opioid or cannabis mobile
phase for LC-MSMS separation and analysis. Set 2 contained QC samples spiked at 10
ng/L with the internal standard and submitted to the same sample preparation and
extraction steps as normal samples. Set 3 contained QC samples spiked at 10 ng/L and
with the internal standard post-extraction. The samples were from four different sources,
one set prepared with UHP water and three sets using authentic wastewater samples that
tested negative for the target drugs. The peak areas for Set 1 and 3 were compared to
determine if there were any matrix effects. The peak areas for the Set 2 and 3 samples
were compared to assess the extraction efficiency, and those for Set 1 and Set 2 were
used to assess the process efficiency.
Identification criteria
The identification criteria included retention time within ±0.2 min of the calibrators
retention time, the presence of two product ions (quantitative and qualitative) and an ion
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ratio within ±20% of the average of the calibrators.
Table 2. Inter- and intra-day imprecision and accuracy for quality controls at 10 and 100 ng/L.
Compound

Imprecision (%)
Inter-day (n=5)

Accuracy (%)

Intra-day (n=4)

Inter-day (n=5)

Intra-day (n=4)

10 (ng/L)

100 (ng/L)

10 (ng/L)

100 (ng/L)

10 (ng/L)

100 (ng/L)

10 (ng/L)

100 (ng/L)

Morphine

11.4

6.2

5.6

3.4

93.3

94.7

116.0

110.9

Oxymorphone

10.8

3.9

4.9

3.3

106.5

106.6

126.5

109.1

Hydromorphone

14.1

3.3

12.9

4.4

98.3

103.3

119.5

121.1

8.9

7.6

10.9

5.0

98.3

101.1

110.0

102.0

10.0

8.8

6.1

4.8

107.5

103.7

131.0

127.2

THC

9.7

9.0

21.2

7.9

102.8

98.8

110.3

106.6

THCCOOH
THCCOOHGlucuronide

8.0

6.1

5.0

7.3

97.3

105.6

119.3

103.4

6.0

10.3

4.1

5.5

95.0

98.9

83.0

102.3

Oxycodone
Hydrocodone

Results
Method validation
The LOQ and LOD for all opioids were 5 and 1 ng/L, respectively, and the linear range
was 5–1,000 ng/L. For the cannabinoids, the LOQ, LOD and linear range were 10, 5 and
10–1,000 ng/L, respectively. Acceptable linearity for opioids and cannabinoids (R 2 ≥
0.99 and residuals within ±20%) were achieved with 1/x2 weighting. No endogenous or
exogenous interferences were detected.
For opioids, the intra- and inter-day imprecision were 3.3% to 14.1%,
respectively, and the accuracy was 93.3%–131.0%. For cannabinoids, the intra and interday imprecision were 4.1% to 21.2%, respectively, and the accuracy was 83.0% to
119.3%. For opioids, the extraction efficiency range was 75.0%–84.0%, and the process
efficiency range from 63.1% to 73.3%. For cannabinoids, the extraction efficiency range
was 25.4%– 66.5% and the process efficiency range was 22.7%– 62.7%. For opioids, the
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matrix effects range was –35.1% to –7.6% (ion suppression), with a coefficient of
variation of 28.3% (n = 4). For cannabinoids, the matrix effects range was –14.7% to –
5.8%, with a coefficient of variation of 13.9% (n = 4). These results are summarized in
Tables 2 and 3.
Carryover was assessed by injecting a blank after injection of a sample prepared
at 2,000 ng/L (twice the concentration of the highest calibrator). The results for all target
compounds for the blank were below LOD. Autosampler stability was assessed by
injecting the same samples fresh and after 24 h in the autosampler at 10 °C. The mean
concentrations from these injections were compared to determine the percentage
difference. The concentrations of all target compounds were within the accepted 20%,
except for oxymorphone (–21.3%).
Table 3. Extraction efficiency, process efficiency, matrix efficient (n=4).
Extraction
Process
Matrix
Matrix
Compound
Efficiency Efficiency
Effect
Effect
(%)
(%)
(%)
CV
Morphine

79.0

73.3

-7.6

9.9

Oxymorphone

84.0

63.1

-24.5

8.7

Hydromorphone

75.0

48.8

-35.1

28.3

Oxycodone

82.0

63.5

-23.1

21.7

Hydrocodone

84.0

72.6

-13.8

16.1

THC

25.4

22.7

-10.6

13.9

THCCOOH

66.5

62.7

-5.8

11.6

THCCOOHGlucuronide

53.1

45.3

-14.7

9.5

Application to authentic samples
Samples from the East and Hudson rivers tested negative for morphine, prescription
opioids and cannabis. Samples from sewage overflows (Newtown Creek, Brooklyn)
tested positive for morphine (10.7 ng/L), oxycodone (4.2–23.5 ng/L), oxymorphone (4.8
ng/L) and hydromorphone (4.2 ng/L). Wastewater samples from the Tallman and Jamaica
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plants in Queens tested positive for morphine (133.0–258.3 ng/L), oxycodone (31.1–63.6
ng/L), oxymorphone (16.0–56.8 ng/L), hydromorphone (6.8–18.0 ng/L), hydrocodone
(4.0– 12.8 ng/L) and THCCOOH (168.2–772.0 ng/L) (Table 4). Figure 3 shows a
chromatogram of an authentic wastewater sample that tested positive for opioids and
cannabinoids.
Table 4. Results from wastewater plants (Tallman and Jamaica, New York City, NY) collected at one
time point 1-3 days before and after national holidays (Independence Day, July 4, 2015; Labor Day,
September 7, 2015; New Year’s Day, January 1, 2016) and March 2016
Analyte

Concentration
range (ng/L)

N cases

Morphine

133.0 – 258.0

5

Hydrocodone

4.0 – 12.8

4

Oxycodone

31.1 – 63.6

5

Oxymorphone

16.0 – 56.8

5

Hydromorphone

6.8 – 10.0

5

THCCOOH

168.2 – 641.4

5

Discussion
We developed and validated a method for the detection of morphine, oxymorphone,
oxycodone, hydromorphone, hydrocodone, THC and its metabolites THCCOOH and
THCOOH-glucuronide in wastewater samples. Numerous methods for the analysis of
licit and illicit drugs in wastewater samples have been published (Baker & KasprzykHordern, 2011; Berset et al., 2010; Bijlsma et al., 2009; Bisceglia et al., 2010; Boleda et
al., 2007; Castiglioni et al., 2006; Chiaia et al., 2008; Fedorova et al., 2013; GonzálezMariño et al., 2012; Gul et al., 2016; Heuett et al., 2015; Hummel et al., 2006;
Mastroianni et al., 2013; Postigo & Alda, 2008; Senta et al., 2013; Vazquez-Roig et al.,
2010). These analytical methods allow for the quantification of opiates and prescription
opioids (Baker & Kasprzyk-Hordern, 2011; Bisceglia et al., 2010; Chiaia et al., 2008; Gul
et al., 2016; Hummel et al., 2006), cannabis (Bijlsma et al., 2009; Fedorova et al., 2013)
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or both classes of compounds, opiates and cannabis (Baker & Kasprzyk-Hordern, 2011;
Berset et al., 2010; Castiglioni et al., 2006; Fedorova et al., 2013; González-Mariño et al.,
2012; Heuett et al., 2015; Mastroianni et al., 2013; Postigo & Alda, 2008; Senta et al.,
2013). In the case of opiates, most of the methods can only detect morphine (Baker &
Kasprzyk-Hordern, 2011; Berset et al., 2010; Bisceglia et al., 2010; Boleda et al., 2007;
Castiglioni et al., 2006; González-Mariño et al., 2012; Gul et al., 2016; Heuett et al.,
2015; Hummel et al., 2006; Mastroianni et al., 2013; Postigo & Alda, 2008; Senta et al.,
2013; Vazquez-Roig et al., 2010), although some methods are suitable for prescription
opioids such as oxycodone, oxymorphone, hydrocodone and hydromorphone (Baker &
Kasprzyk-Hordern, 2011; Bisceglia et al., 2010; Chiaia et al., 2008; Fedorova et al.,
2013; Gul et al., 2016; Heuett et al., 2015; Hummel et al., 2006). With regard to cannabis,
most methods have been developed for THCCOOH (Berset et al., 2010; Bijlsma et al.,
2009; Castiglioni et al., 2006; Fedorova et al., 2013; Senta et al., 2013) or for THC or
THC and THCCOOH (Boleda et al., 2007; González-Mariño et al., 2012; Heuett et al.,
2015; Mastroianni et al., 2013; Postigo & Alda, 2008; Vazquez-Roig et al., 2010). There
is no data available for THCCOOH-glucuronide in wastewater samples, even though this
compound is the predominant THC metabolite in human urine (Desrosiers et al., 2014).
This may be because glucuronides are normally hydrolyzed in wastewater (Ternes,
1998), resulting in higher concentrations of the free compound. However, recent
publications have reported high concentrations of glucuronides in wastewater samples
(Wang & Gardinali, 2014; Zonja, Perez, & Barcelo, 2016). These results highlight the
need for a method for detection of glucuronides in wastewater.
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Currently, the most commonly used instrument for wastewater analysis is LCMSMS. However, gas chromatography-mass spectrometry has been used as well
(González-Mariño, Quintana, Rodríguez, & Cela, 2010). In the present method, all
compounds were ionized in positive mode using dual ionization sources (atmospheric
pressure chemical/electrospray ionization), despite other authors finding better sensitivity
for cannabinoids in negative ionization mode (electrospray ionization) (Castiglioni et al.,
2006; González-Mariño et al., 2012; Postigo & Alda, 2008; Senta et al., 2013). The
sensitivity of our method (LOD 1–5 ng/L and LOQ 5–10 ng/L in 100 mL of wastewater)
was within the range of methods in previous publications (Berset et al., 2010; Bisceglia et
al., 2010; Fedorova et al., 2013; Mastroianni et al., 2013). Earlier studies have reported
LOQs for the compounds of interest as low as 0.48 ng/L (Zuccato et al., 2008) and as
high as 100 ng/L (Berset et al., 2010) for wastewater volumes between 15 mL (Gul et al.,
2016) and 250 mL (Boleda et al., 2007). Sample preparation usually involves filtration
and SPE with a reversed-phase (Oasis HLB, Waters Corp., Milford, MA, USA) or cation
exchange (Oasis MCX, Waters Corp.) cartridges.
During method validation, matrix effect experiments were carried out using four
different matrices instead of six (“Scientific working group for forensic toxicology
(SWGTOX) standard practices for method validation in forensic toxicology,” 2013). This
limitation was because it was difficult to obtain wastewater samples that were negative
for the compounds of interest. Another limitation of the present method was the intra-day
accuracy above the established criteria for three opioids. Although oxymorphone’s low
QC, hydromorphone’s high QC and hydrocodone’s low and high QC gave an intra-day
accuracy >120% (121.1% to 131%), the rest of the validation parameters were within the
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established range (“Scientific working group for forensic toxicology (SWGTOX)
standard practices for method validation in forensic toxicology,” 2013).

Figure 3. Multiple reaction monitoring chromatograms of an authentic wastewater sample from
Tallman Island Wastewater Treatment Plant (Queens, NYC) showing positive results for THCCOOH
(184.1 ng/L), morphine (181.9 ng/L), hydromorphone (10.0 ng/L), oxymorphone (56.8 ng/L),
oxycodone (63.3 ng/L) and hydrocodone (10.3 ng/L).

As a proof of concept, we were able to detect THCCOOH, morphine and
prescription opiates in water samples from sewage overflow locations and wastewater
treatment plants. The concentrations of morphine (10.7– 258.3 ng/L), oxycodone (4.2–
63.6 ng/L), oxymorphone (4.8–56.8 ng/L), hydromorphone (4.2–18.0 ng/L), hydrocodone
(4.0–12.8 ng/L) and THCCOOH (168.2–772.0 ng/L) were similar to those found in
previous studies (Baker & Kasprzyk-Hordern, 2011; Fedorova et al., 2013; Gul et al.,
2016; “Scientific working group for forensic toxicology (SWGTOX) standard practices
for method validation in forensic toxicology,” 2013; Wang & Gardinali, 2014). THC and
THCCOOH-glucuronide were not detected in any of the analyzed samples. Previously,
THC was detected in wastewater samples (Boleda et al., 2007), but there are no reports of
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the detection of THCCOOH-glucuronide. Continued research is required to investigate
the importance of monitoring THCCOOH-glucuronide’s in these types of samples, and to
back calculate the drug exposure in communities based on wastewater drug
concentrations.

Conclusion
We developed and validated an analytical method for the extraction, detection, and
quantification of morphine, common prescription opioids (oxycodone, oxymorphone,
hydrocodone and hydromorphone), and THC, THCCOOH and THCCOOH-glucuronide
in wastewater samples. This technique was sensitive (LOD 1–5 ng/L and LOQ 5–10 ng/L
in 100 mL of sample) and specific. This is the first report of testing for THCCOOHglucuronide in wastewater samples. As a proof of concept, we were able to detect
THCCOOH, morphine, and prescription opioids in samples from sewage overflow
locations and wastewater plants throughout NYC.
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